Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1128/AAC.02189-13 http://repositorio.unifesp.br/handle/11600/37578 |
Resumo: | We identified a case of breakthrough candidemia in a 25-year-old patient receiving micafungin prophylaxis (50 mg/day). Five Candida glabrata isolates were obtained from blood cultures and were classified as multidrug-resistant isolates, since all of them exhibited high MICs for echinocandin and azole drugs. A mutation (S663F) in hot spot 1 of the FKS2 gene was found in all five isolates. This mutation yielded a 1,3-beta-D-glucan synthase enzyme with highly reduced sensitivities to echinocandin drugs. |
id |
UFSP_513591f7cbe46b470a041bcffc39ba82 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/37578 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of MicafunginWe identified a case of breakthrough candidemia in a 25-year-old patient receiving micafungin prophylaxis (50 mg/day). Five Candida glabrata isolates were obtained from blood cultures and were classified as multidrug-resistant isolates, since all of them exhibited high MICs for echinocandin and azole drugs. A mutation (S663F) in hot spot 1 of the FKS2 gene was found in all five isolates. This mutation yielded a 1,3-beta-D-glucan synthase enzyme with highly reduced sensitivities to echinocandin drugs.Universidade Federal de São Paulo, Lab Especial Micol, Disciplina Infectol, São Paulo, BrazilUniv Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, BrazilRutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USAUniversidade Federal de São Paulo, Lab Especial Micol, Disciplina Infectol, São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)NIHPfizerMerckAstellasMSDUnited MedicalFAPESP: 2007/08575-1FAPESP: 2012/04767-1CNPq: 308011/2010-4FAPESP: 2012/04769-4FAPESP: 2010/17179-5NIH: AI069397Amer Soc MicrobiologyUniversidade Federal de São Paulo (UNIFESP)Univ Fed ParanaRutgers State UnivBizerra, Fernando Cesar [UNIFESP]Jimenez-Ortigosa, CristinaSouza, Ana Carolina R. [UNIFESP]Breda, Giovanni LuisQueiroz-Telles, FlavioPerlin, David S.Colombo, Arnaldo L. [UNIFESP]2016-01-24T14:35:29Z2016-01-24T14:35:29Z2014-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion2438-2440application/pdfhttp://dx.doi.org/10.1128/AAC.02189-13Antimicrobial Agents and Chemotherapy. Washington: Amer Soc Microbiology, v. 58, n. 4, p. 2438-2440, 2014.10.1128/AAC.02189-13WOS000333605600079.pdf0066-4804http://repositorio.unifesp.br/handle/11600/37578WOS:000333605600079engAntimicrobial Agents and Chemotherapyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-31T21:25:22Zoai:repositorio.unifesp.br/:11600/37578Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-31T21:25:22Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
title |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
spellingShingle |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin Bizerra, Fernando Cesar [UNIFESP] |
title_short |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
title_full |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
title_fullStr |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
title_full_unstemmed |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
title_sort |
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin |
author |
Bizerra, Fernando Cesar [UNIFESP] |
author_facet |
Bizerra, Fernando Cesar [UNIFESP] Jimenez-Ortigosa, Cristina Souza, Ana Carolina R. [UNIFESP] Breda, Giovanni Luis Queiroz-Telles, Flavio Perlin, David S. Colombo, Arnaldo L. [UNIFESP] |
author_role |
author |
author2 |
Jimenez-Ortigosa, Cristina Souza, Ana Carolina R. [UNIFESP] Breda, Giovanni Luis Queiroz-Telles, Flavio Perlin, David S. Colombo, Arnaldo L. [UNIFESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Univ Fed Parana Rutgers State Univ |
dc.contributor.author.fl_str_mv |
Bizerra, Fernando Cesar [UNIFESP] Jimenez-Ortigosa, Cristina Souza, Ana Carolina R. [UNIFESP] Breda, Giovanni Luis Queiroz-Telles, Flavio Perlin, David S. Colombo, Arnaldo L. [UNIFESP] |
description |
We identified a case of breakthrough candidemia in a 25-year-old patient receiving micafungin prophylaxis (50 mg/day). Five Candida glabrata isolates were obtained from blood cultures and were classified as multidrug-resistant isolates, since all of them exhibited high MICs for echinocandin and azole drugs. A mutation (S663F) in hot spot 1 of the FKS2 gene was found in all five isolates. This mutation yielded a 1,3-beta-D-glucan synthase enzyme with highly reduced sensitivities to echinocandin drugs. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-04-01 2016-01-24T14:35:29Z 2016-01-24T14:35:29Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1128/AAC.02189-13 Antimicrobial Agents and Chemotherapy. Washington: Amer Soc Microbiology, v. 58, n. 4, p. 2438-2440, 2014. 10.1128/AAC.02189-13 WOS000333605600079.pdf 0066-4804 http://repositorio.unifesp.br/handle/11600/37578 WOS:000333605600079 |
url |
http://dx.doi.org/10.1128/AAC.02189-13 http://repositorio.unifesp.br/handle/11600/37578 |
identifier_str_mv |
Antimicrobial Agents and Chemotherapy. Washington: Amer Soc Microbiology, v. 58, n. 4, p. 2438-2440, 2014. 10.1128/AAC.02189-13 WOS000333605600079.pdf 0066-4804 WOS:000333605600079 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Antimicrobial Agents and Chemotherapy |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
2438-2440 application/pdf |
dc.publisher.none.fl_str_mv |
Amer Soc Microbiology |
publisher.none.fl_str_mv |
Amer Soc Microbiology |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268432663707648 |